Galectin-3 in Renal Pathology: More Than Just an Innocent Bystander?

被引:61
作者
Desmedt, Valerie [1 ]
Desmedt, Stephanie [1 ]
Delanghe, Joris R. [2 ]
Speeckaert, Reinhart [2 ]
Speeckaert, Marijn M. [1 ]
机构
[1] Ghent Univ Hosp, Dept Nephrol, De Pintelaan 185, BE-9000 Ghent, Belgium
[2] Ghent Univ Hosp, Dept Clin Chem, BE-9000 Ghent, Belgium
关键词
Galectin-3; Kidney disease; Lectin; Renal fibrosis; CARBOHYDRATE-RECOGNITION DOMAIN; FAMILIAL MEDITERRANEAN FEVER; POLYCYSTIC KIDNEY-DISEASE; HEART-FAILURE PATIENTS; EPITHELIAL-CELLS; KNOCKOUT MICE; HYPERTENSIVE NEPHROPATHY; INTERSTITIAL FIBROSIS; DIABETIC-NEPHROPATHY; SERUM GALECTIN-3;
D O I
10.1159/000446376
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Galectin-3 is a member of a closely related lectin family, which is detected in several vertebrate epithelial and myeloid cell types. This beta-galactoside-binding soluble protein plays an important role in multiple biological processes. Depending on its location, type of injury or site of damage, the effects by galectin-3 can be various and sometimes contrasting. Summary: In this review, we discuss the general characteristics and functions of galectin-3. More specifically, we focus on the role of galectin-3 in the onset and development of diabetic and non-diabetic nephropathies. Finally, the therapeutic potential of anti-galectin-3 inhibitors is discussed. Key Messages: Due to its multifunctional character, galectin-3 plays a pivotal role in interstitial fibrosis and progression of chronic kidney disease. Inhibition of galectin-3 may be a promising therapeutic strategy to prevent end-stage renal disease. (C) 2016 S. Karger AG, Basel
引用
收藏
页码:305 / 317
页数:13
相关论文
共 92 条
[21]   Pharmacological inhibition of galectin-3 protects against hypertensive nephropathy [J].
Frenay, Anne-Roos S. ;
Yu, Lili ;
van der Velde, A. Rogier ;
Vreeswijk-Baudoin, Inge ;
Lopez-Andres, Natalia ;
van Goor, Harry ;
Sillje, Herman H. ;
Ruifrok, Willem P. ;
de Boer, Rudolf A. .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2015, 308 (05) :F500-F509
[22]   Galectin-3 Regulates Integrin α2β1-mediated Adhesion to Collagen-I and -IV [J].
Friedrichs, Jens ;
Manninen, Aki ;
Muller, Daniel J. ;
Helenius, Jonne .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (47) :32264-32272
[23]   RAGE-mediated interstitial fibrosis in neonatal obstructive nephropathy is independent of NF-κB activation [J].
Gasparitsch, Mojca ;
Arndt, Anne-Karin ;
Pawlitschek, Felix ;
Oberle, Stephan ;
Keller, Ursula ;
Kasper, Michael ;
Bierhaus, Angelika ;
Schaefer, Franz ;
Weber, Lutz T. ;
Lange-Sperandio, Baerbel .
KIDNEY INTERNATIONAL, 2013, 84 (05) :911-919
[24]   Analytical evaluation of the automated galectin-3 assay on the Abbott ARCHITECT immunoassay instruments [J].
Gaze, David C. ;
Prante, Christian ;
Dreier, Jens ;
Knabbe, Cornelius ;
Collet, Corinne ;
Launay, Jean-Marie ;
Franekova, Janka ;
Jabor, Antonin ;
Lennartz, Lieselotte ;
Shih, Jessie ;
del Rey, Jose Manuel ;
Zaninotto, Martina ;
Plebani, Mario ;
Collinson, Paul O. .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (06) :919-926
[25]   Relationship of Plasma Galectin-3 to Renal Function in Patients With Heart Failure: Effects of Clinical Status, Pathophysiology of Heart Failure, and Presence or Absence of Heart Failure [J].
Gopal, Deepa M. ;
Kommineni, Maya ;
Ayalon, Nir ;
Koelbl, Christian ;
Ayalon, Rivka ;
Biolo, Andreia ;
Dember, Laura M. ;
Downing, Jill ;
Siwik, Deborah A. ;
Liang, Chang-seng ;
Colucci, Wilson S. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2012, 1 (05) :e000760
[26]   Galectin-3 testing: Validity of a novel automated assay in heart failure patients with reduced ejection fraction [J].
Gruson, D. ;
Mancini, M. ;
Ahn, S. A. ;
Rousseau, M. F. .
CLINICA CHIMICA ACTA, 2014, 429 :189-193
[27]   Autosomal recessive polycystic kidney disease: The clinical experience in North America [J].
Guay-Woodford, LM ;
Desmond, RA .
PEDIATRICS, 2003, 111 (05) :1072-1080
[28]   Recognition of galactan components of pectin by galectin-3 [J].
Gunning, A. Patrick ;
Bongaerts, Roy J. M. ;
Morris, Victor J. .
FASEB JOURNAL, 2009, 23 (02) :415-424
[29]   Hypertensive nephropathy: prevention and treatment recommendations [J].
Hart, Peter D. ;
Bakris, George L. .
EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (16) :2675-2686
[30]   Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis [J].
Henderson, Neil C. ;
Mackinnon, Alison C. ;
Farnworth, Sarah L. ;
Kipari, Tiina ;
Haslett, Christopher ;
Iredale, John P. ;
Liu, Fu-Tong ;
Hughes, Jeremy ;
Sethi, Tariq .
AMERICAN JOURNAL OF PATHOLOGY, 2008, 172 (02) :288-298